🇺🇸 FDA
Patent

US 11919963

CD123-binding polypeptides and uses thereof

granted A61KA61K45/06A61P

Quick answer

US patent 11919963 (CD123-binding polypeptides and uses thereof) held by Inhibrx, Inc. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx, Inc.
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K45/06, A61P, A61P35/00